We are live on ! Find out more
EC

Elequin Capital Portfolio holdings

AUM $1.19B
1-Year Est. Return 16.08%
This Fund
S&P 500
This Quarter Est. Return
-5.61%
1 Year Est. Return
+16.08%
3 Year Est. Return
+46.25%
5 Year Est. Return
10 Year Est. Return
AUM
$267M
AUM Growth
-$170M
Cap. Flow
-$43.3M
Cap. Flow %
-16.21%
Top 10 Hldgs %
79.28%
Holding
746
New
321
Increased
50
Reduced
153
Closed
192
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MIR.WS
276
DELISTED
Mirion Technologies, Inc. Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
MIR.WS
$9K ﹤0.01%
+6,009
New +$8.15K
PNTM
277
DELISTED
Pontem Corporation
PNTM
$9K ﹤0.01%
+859
New +$8.5K
ISAA
278
DELISTED
Iron Spark I Inc. Class A Common Stock
ISAA
$9K ﹤0.01%
+950
New +$9.4K
CRU
279
DELISTED
Crucible Acquisition Corporation
CRU
$9K ﹤0.01%
+902
New +$8.91K
FRW
280
DELISTED
PWP Forward Acquisition Corp. I Class A Common Stock
FRW
$9K ﹤0.01%
+955
New +$9.38K
ARRY icon
281
Array Technologies
ARRY
$803M
$8K ﹤0.01%
474
-321
-40% -$5.55K
ASND icon
282
Ascendis Pharma A/S
ASND
$16B
$8K ﹤0.01%
76
-37
-33% -$3.51K
BL icon
283
BlackLine
BL
$1.84B
$8K ﹤0.01%
137
-120
-47% -$8.05K
LRN icon
284
Stride
LRN
$3.41B
$8K ﹤0.01%
187
-124
-40% -$5K
NSIT icon
285
Insight Enterprises
NSIT
$3.89B
$8K ﹤0.01%
103
-86
-46% -$7.65K
ROCL
286
DELISTED
Roth CH Acquisition V Co. Common Stock
ROCL
$8K ﹤0.01%
+800
New +$7.92K
QDRO
287
DELISTED
Quadro Acquisition One Corp. Class A Ordinary Shares
QDRO
$8K ﹤0.01%
+799
New +$7.88K
CORS
288
DELISTED
Corsair Partnering Corporation
CORS
$8K ﹤0.01%
+803
New +$7.83K
EPHY
289
DELISTED
Epiphany Technology Acquisition Corp. Class A Common Stock
EPHY
$8K ﹤0.01%
+825
New +$8.14K
ARGU
290
DELISTED
Argus Capital Corp. Class A Common Stock
ARGU
$8K ﹤0.01%
+774
New +$7.75K
OHPA
291
DELISTED
Orion Acquisition Corp. Class A common stock
OHPA
$8K ﹤0.01%
+800
New +$7.86K
AEON icon
292
AEON Biopharma
AEON
$12.9M
$7K ﹤0.01%
+10
New +$7.08K
BMRN icon
293
BioMarin Pharmaceuticals
BMRN
$11.6B
$7K ﹤0.01%
87
-152
-64% -$13.5K
MRK icon
294
Merck
MRK
$322B
$7K ﹤0.01%
77
-255
-77% -$22.8K
VAC icon
295
Marriott Vacations Worldwide
VAC
$3.35B
$7K ﹤0.01%
57
-68
-54% -$9.23K
INFN
296
DELISTED
Infinera Corporation Common Stock
INFN
$7K ﹤0.01%
1,357
+41
+3% +$225
FSR
297
DELISTED
Fisker Inc.
FSR
$7K ﹤0.01%
942
+351
+59% +$3.17K
GFX
298
DELISTED
Golden Falcon Acquisition Corp.
GFX
$7K ﹤0.01%
+700
New +$6.93K
NAAC
299
DELISTED
North Atlantic Acquisition Corporation Class A Ordinary Share
NAAC
$7K ﹤0.01%
+750
New +$7.42K
OMEG
300
DELISTED
Omega Alpha SPAC Class A Ordinary Shares
OMEG
$7K ﹤0.01%
+701
New +$6.94K

Similar funds

Elequin Capital's Q3 2022 Portfolio in Review

As of Q3 2022, Elequin Capital held 746 positions worth $267M, down 39% from $437M the previous quarter. Its ten largest holdings account for 79% of the portfolio.

Elequin Capital withdrew a net $43.3M in Q3 2022, closing 192 positions and reducing 153 holdings. Its most notable exit was Broadcom Inc. 8.00% Mandatory Convertible Preferred Stock, Series A, an estimated $140M position sold in full.

By sector, the portfolio is most concentrated in Financials at 14% of assets, up from 9.4% a quarter earlier, followed by Real Estate and Technology.

Against the trend, Elequin Capital opened a new position in Stanley Black & Decker, Inc. worth $41.1M.

  • Elequin Capital's largest Q3 2022 buy was Stanley Black & Decker, Inc.: 850,245 shares worth $41.1M.
  • Elequin Capital added most to South Jersey Industries, Inc. Corporate Units in Q3 2022, an estimated $21.4M increase.
  • Elequin Capital's biggest Q3 2022 reduction was Austerlitz Acquisition Corporation II, cutting an estimated $1.01M.
  • Elequin Capital fully exited Broadcom Inc. 8.00% Mandatory Convertible Preferred Stock, Series A in Q3 2022, selling an estimated $140M.
  • Elequin Capital's ten largest holdings make up 79% of its $267M portfolio in Q3 2022.
  • Elequin Capital opened 321 new positions and closed 192 in Q3 2022.
  • Elequin Capital's portfolio value fell 39% quarter-over-quarter to $267M.

Based on Elequin Capital's 13F filing for Q3 2022, filed 10 Nov 2022.